Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 2 (EIF2S2P2) is a human pseudogene with sequence similarity to a segment of the EIF2S2 protein-coding gene, which encodes a subunit of eukaryotic translation initiation factor 2 involved in the initiation of protein synthesis. As a pseudogene, EIF2S2P2 does not produce a functional protein and is generally regarded as non-functional in biological processes; it is not recognized as a therapeutic target, and no disease associations or drug interactions have been reported[1]. *Do not confuse this with the active, protein-coding EIF2S2 gene, which has known biological roles and possible disease relevance[3][5].* Note: If your inquiry was regarding the canonical, protein-coding EIF2S2 gene (not the pseudogene), that is a different entity with distinct clinical relevance and biological functions[3][5]. This entry refers specifically to the pseudogene ENSG00000217078/EIF2S2P2, which is non-coding.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Eukaryotic translation initiation factor 2 subunit 2 beta pseudogene 2 (EIF2S2P2).